Attached files
file | filename |
---|---|
8-K - CURRENT REPORT - cbdMD, Inc. | ycbd_8k.htm |
Exhibit 99.1
|
1
(800) 973-3984
info@cbdMD.com
|
cbdMD Files New Patent Application to Advance Its Strategy to
Broaden Intellectual Property Portfolio
Patent
Application Seeks Patent Protection for a Wide Range of Novel CBD
Technologies and Methods
Charlotte,
NC, July 13, 2020, cbdMD, Inc. (NYSE American: YCBD, YCBD PR A),
one of the leading, most trusted and most recognized cannabidiol
(CBD) consumer brands, announced today that it has filed a new
patent application with the U.S. Patent and Trademark Office which
will allow it to pursue patented protection in several key areas,
including novel formulations and delivery systems, as well as
methods of manufacturing and use. The recent submission by the
company is part of its ongoing intellectual property strategy to
ensure appropriate protection around its product lines and to be
forward-thinking as to the direction of the CBD
market.
“cbdMD
has always been a leader of innovation the CBD
industry. Pursuing intellectual property will remain a
priority for us as we continue to strengthen and grow the
company’s assets within a fiscally disciplined
mindset,” said Martin A. Sumichrast, Chairman and co-CEO at
cbdMD, Inc. “The filing of this new patent application
furthers supports our mission of being a preeminent science-based
company in a currently congested CBD marketplace. Continued
research and development for real world applications drives
innovation and protecting those proprietary technologies and ideas
is consistent with cbdMD’s business plan. We look
forward to our future innovation and continuing to pursue
additional IP protection.”
About cbdMD
cbdMD, Inc. is one of the leading, most trusted and most
recognized cannabidiol (CBD) consumer brands, whose current products include CBD tinctures, CBD
capsules, CBD gummies, CBD topicals, CBD bath bombs and CBD pet
products. cbdMD is also a proud partner of Bellator MMA and Life
Time, Inc., and has one of the largest rosters of professional
sports athletes who are part of “Team cbdMD.” To learn
more about cbdMD and our comprehensive line of over 100 SKUs of
U.S. produced, THC-free1 CBD
products, please visit www.cbdMD.com,
follow cbdMD on Instagram
and Facebook,
or visit one of the 6,000 retail outlets that carry cbdMD
products.
Forward-Looking Statements
This press release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
The words "believe," "may," "estimate," "continue," "anticipate,"
"intend," "should," "plan," "could," "target," "potential," "is
likely," "will," "expect" and similar expressions, as they relate
to us, are intended to identify forward-looking statements. cbdMD,
Inc. has based these forward-looking statements largely on our
current expectations and projections about our ability to protect
our intellectual property, the granting of the patent by the U.S.
Patent and Trademark Office, and future events and financial trends
that we believe may affect our financial condition, results of
operations, business strategy and financial needs. Some or all of
the results anticipated by these forward-looking statements are
unknown at this time. Further information on cbdMD’s risk
factors is contained in Annual Report on Form 10-K for the year
ended September 30, 2019, as amended, Part II, Item 1A. Risk
Factors appearing in our Quarterly Report on Form 10-Q for the
period ended March 31, 2020, and our other filings with the
Securities and Exchange Commission. Any forward-looking statement
made by us herein speaks only as of the date on which it is made.
Factors or events that could cause our actual results to differ may
emerge from time to time, and it is not possible for us to predict
all of them. cbdMD, Inc. undertakes no obligation to publicly
update any forward-looking statement, whether as a result of new
information, future developments or otherwise, except as may be
required by law. The information which appears on our websites and
our social media platforms, including, but not limited to,
Instagram and Facebook, is not part of this press
release.
PR:
cbdMD,
Inc.
Lauren
Greene, 843-743-9999
Lauren.greene@cbdmd.com
Investors:
cbdMD,
Inc.
John
Weston, 704-445-3060 ext. 1103
john.weston@cbdmd.com